Table 1.
Summary of AVM patient characteristics.
| Variable | Value |
|---|---|
| Subjects, N | 26 |
| Median age, years (IQR) | 41 (26–55) |
| Gender | |
| Male, n (%) | 15 (58) |
| Female, n (%) | 11 (42) |
| Smoking status | |
| Current/prior history, n (%) | 10 (38) |
| Never, n (%) | 12 (46) |
| Unknown, n (%) | 4 (15) |
| Pre-treatment neurological symptoms | |
| Headache, n (%) | 12 (46) |
| Seizures, controlled/uncontrolled, n/n (%/%) | 2/2 (8/8) |
| Motor deficits, n (%) | 9 (35) |
| Pre-treatment hemorrhage, n (%) | 14 (54) |
| Hypertension (%) | 7 (27) |
| Pre-treatment hemorrhage, n (%) | 6 (86) |
| No pre-treatment hemorrhage, n (%) | 1 (14) |
| Spetzler martin grade | |
| I, n (%) | 7 |
| II, n (%) | 12 |
| III, n (%) | 6 |
| IV, n (%) | 1 |
| Median Nidus volume, cm3 (IQR) | 1.62 (0.57–8.26) |
| Intervention | |
| SRS only, n (%) | 17 (65) |
| SRS + embolization or surgery, n (%) | 9 (35) |
| Isodose, median % (IQR) | 80 (76–83%) |
| Dose, median cGy (IQR) | 1900 (1800–2175) |